BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Avigen

Avigen is a leader in the development of gene therapy products derived from adeno-associated virus ("AAV") for the treatment of inherited diseases. Avigen's proposed gene therapy products are designed for in vivo administration to achieve the production of therapeutic proteins within the body. Avigen has honed it's strategic focus on developing a broad-based proprietary gene delivery technology, AAV vector. Avigen believes AAV vectors can be used to deliver genes for the treatment of hemophilia, thalassemia, hereditary emphysema and Gaucher's disease.


Contact Details:
1301 Harbor Bay Parkway
Alameda
94502
United States of America
Tel:510 748 7150
Fax:510-748-7155
Email:info@avigen.com
WWW:

www.avigen.com/




Recent Publications by Avigen:

Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A.
AV513 is a select fucoidan, a sulfated polysaccharide of botanical origin....
12th March, 2008
Research and Development, Avigen, Alameda, CA 94502, USA. Blood. 2008 Jan 15;111(2):672-9. Epub 2007 Oct 31.
DOI Direct Link
The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain.
Controlling neuropathic pain is an unmet medical need and we set out to...
8th January, 2008
Department of Preclinical Development Avigen Inc. Alameda, CA USA. Neuron Glia Biol. 2006 Nov;2(4):279-91.
DOI Direct Link
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats.
Paclitaxel is a commonly used cancer chemotherapy drug that frequently...
1st September, 2007
Department of Psychology & the Center for Neuroscience, University of Brain Behav Immun. 2007 Jul;21(5):686-98. Epub 2006 Dec 15.
DOI Direct Link
Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs.
Hemophilia A, a deficiency of functional coagulation factor VIII (FVIII),...
19th August, 2007
Blood. 2006 Jul 1;108(1):107-15. Epub 2006 Mar 7.
DOI Direct Link
Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes.
The treatment of neuropathic pain is a major unresolved medical challenge....
24th July, 2007
Avigen, Inc., Department of Preclinical Development, Alameda, CA 94502, Expert Opin Investig Drugs. 2007 Jul;16(7):935-50.
DOI Direct Link

View more Avigen research publications.

BioNews Results for Avigen:

Biotech real estate survey: Alameda hot EUR for now
East Bay Business Journal:  Sep 26 2008 7:05PM Matching: avigen
Avigen completes Phase IIb spasticity trial
Pharmaceutical Business Review:  Sep 20 2008 11:54AM Matching: avigen
Avigen completes Phase IIb spasticity trial
Datamonitor:  Sep 19 2008 11:34PM Matching: avigen
Avigen Completes Multi-Center AV650 Phase 2b Spasticity Trial in Patients With Multiple Sclerosis
Pharma Live:  Sep 19 2008 2:31PM Matching: avigen
Avigen to Present At UBS Global Life Sciences Conference
Interest!ALERT:  Sep 18 2008 11:21AM Matching: avigen
Promote your company here: BioNewsCast - Press Release Distribution

View more Avigen news.

Avigen Patents:

US Patent No.Title
7037713 High-efficiency wild-type-free AAV helper functions
6242426 Induction of immune response to antigens expressed by recombinant adeno-associated virus
6221349 Adeno-associated vectors for expression of factor VIII by target cells
6218180 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
6211163 Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors

View more Avigen patents.

Avigen (AVGN) Financial information Links from Barchart

AVGN Quote from from Barchart.com
AVGN Chart from from Barchart.com
AVGN Profile from from Barchart.com
AVGN Opinion from from Barchart.com

View more Avigen finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 232 times since April 2007, the link to the organisation's website has been followed 49 times

Recent Search Terms used to find this page: info@avigen | @avigen.com | AV411 | Avigen chickens | Avigen Inc - 1301 Harbor Bay USA | .

Search for more companies in Alameda

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Avigen
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.